To evaluate mitral-aortic flow velocity integral ratio (MAVIR) as an echocardiographic tool to differentiate between severe and nonsevere mitral regurgitation (MR), compared with regurgitant volume (RVol) and effective regurgitant orifice area (EROA), with subgroup analysis in patients with calcific mitral valve, both by transthoracic (TTE) and transesophageal (TEE) echocardiography. Also, whether MAVIR can be used as a screening tool for severe MR.
Prospective, cross-sectional, observational.
Cardiac operating room of a tertiary-care hospital.
One hundred adult patients with chronic mitral regurgitation with at least mild MR by two-dimensional Doppler and with absence of mitral stenosis, aortic valve disease, and rhythm other than sinus scheduled for cardiac surgery. The subgroup (n = 24) consisted specifically of patients with a calcific mitral valve.
Preinduction TTE and postinduction TEE in the operating room.
Measurements and Results
MAVIR, RVol, and EROA were measured in all patients both by TTE and TEE. Cohen's kappa statistics was employed to quantify concordance among RVol, EROA, and MAVIR. Diagnostic indices of MAVIR toward diagnosis of severe MR also were quantified.
The results showed a strong agreement, in differentiating severe from nonsevere MR, between MAVIR and both RVol and EROA in the whole cohort (n = 100) and the subgroup (n = 24), both by TTE and TEE. Diagnostic indices were high for MAVIR compared with RVol and EROA in detecting severe MR, both by TTE and TEE.
MAVIR may be used as an echocardiographic tool to differentiate between severe and nonsevere MR, even in patients with calcific valves. It also can be used to screen patients for severe MR.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Native valvular regurgitation. A report from the American Society of Echocardiography developed in collaboration with the Society of Cardiovascular Magnetic Resonance.J Am Soc Echocardiogr. 2017; : 303-371
- Two-dimensional color Doppler estimation of atrioventricular valve regurgitation: important effects on instrument gain setting, pulse repetition frequency and carrier frequency.J Am Soc Echocardiogr. 1989; 2: 1-10
- Utility of three-dimensional ultrasound Doppler flow reconstruction of the proximal jet to quantify effective orifice area. In vitro study and pulsatile flow studies.J Am Soc Echocardiogr. 1998; 11: 313-321
- Influence of the Coanda effect on color Doppler jet area and color encoding. In vitro studies using color Doppler flow mapping.Circulation. 1992; 85: 333-341
- Real-world echocardiography in patients referred for mitral valve surgery. The gap between guidelines and clinical practice.J Heart Valve Dis. 2014; 23: 721-726
- Usefulness of the mitral/aortic flow velocity-integral ratio as a screening method to identify patients with hemodynamically significant mitral regurgitation.J Am Soc of Echocardiogr. 2003; 16: 437-441
- The natural history of rheumatic heart disease in the third, fourth and fifth decades of life: I: prognosis with special reference to survivorship.Circulation. 1957; 16: 700-712
- Valve repair improves the outcome of surgery for mitral regurgitation: A multivariate analysis.Circulation. 1995; 91: 1022-1028
- The mitral-to-aortic flow-velocity integral ratio in the real world echocardiographic evaluation of functional mitral regurgitation before and after percutaneous repair.J Interven Cardiol. 2017; 30: 368-373
- The mitral/aortic flow velocity integral ratio in mitral regurgitation.J Cardiothoracic Vascular Anesthesia. 2020; 34: 289-293
Published online: October 08, 2022
© 2022 Elsevier Inc. All rights reserved.